Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;72(3):482-9.
doi: 10.1111/j.1365-2125.2011.04010.x.

Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria

Chirn-Bin Chang  1 , Jen-Hau Chen, Chiung-Jung Wen, Hsu-Ko Kuo, I-Shu Lu, Lee-Shu Chiu, Shwu-Chong Wu, Ding-Cheng Derrick Chan
Affiliations

Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria

Chirn-Bin Chang et al. Br J Clin Pharmacol. 2011 Sep.

Abstract

Aim: Our aim was to compare the practicability of six different potentially inappropriate medication (PIM) criteria in geriatric outpatients with polypharmacy.

Methods: We analysed baseline data from the Medication Safety Review Clinic in Taiwanese Elders (MSRC-Taiwan) study. The prevalence and correlates of PIMs were determined on the basis of criteria developed in the USA, Canada, France, Norway, Ireland and Thailand. The percentage of PIMs considered as drug-related problems and the problem-solving rate are reported.

Results: In the 193 participants, the prevalence of PIM varied from 24 to 73%. Application of the criteria revealed that a high number of chronic medications was a common risk factor for having at least one PIM. Of the 1713 medications reviewed, 5.6-14.8% were considered PIMs. Only 30-40% of the identified PIMs were reported as drug-related problems by the MSRC team experts. Criteria with a higher number of statements and a higher percentage of local market/institution drug availability tended to detect more PIMs.

Conclusions: The prevalence of PIM varied significantly when different criteria were applied. Caution should be exercised in applying PIM criteria developed in other regions when medication availability in the local market is limited.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of potentially inappropriate medications from six sets of explicit criteria (total n = 193). Numbers of patients are shown above the bars. Abbreviations: NORGEP, Norwegian General Practice criteria; STOPP, the Screening Tool of Older Person's Prescriptions. No PIM (▪); 1 PIM (formula image); 2 PIMs (□); >3 PIMS (formula image)
Figure 2
Figure 2
Person-level analysis of prevalence, number of statements and availability (percentage) of potentially inappropriate medications in National Taiwan University Hospital (NTUH) based on six sets of criteria. Abbreviations: NORGEP, Norwegian General Practice criteria; STOPP, the Screening Tool of Older Person's Prescriptions. Statements (formula image); Availability (%) (formula image); Prevalence (%) (formula image)
See this image and copyright information in PMC

References

    1. PCNE Working Group on Drug-Related Problems. Pharmaceutical Care Network, E. 2006. PCNE articles, sorted by primary authors. Available at http://www.pcne.org/sig/drp/drug-related-problems.php (last accessed 20 May 2011)
    1. van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67. - PubMed
    1. O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37:138–41. - PubMed
    1. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–24. - PubMed
    1. Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med. 2001;135:642–6. - PubMed

Substances